No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study

Schizophrenia Research

Volumn 60, Issue 2-3, 2003, Pages 167-172

  Morris, Derek W ^a   McGhee, Kevin A ^a   Schwaiger, Siobhan ^a   Scully, Paul ^b   Quinn, John ^b   Meagher, David ^b   Waddington, John L ^b,c   Gill, Michael ^a   Corvin, Aiden P ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b St Davnet's Hospital   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Association; DTNBP1; Dysbindin; Schizophrenia

Indexed keywords

BINDING PROTEIN; DYSTROBREVIN BINDING PROTEIN 1; PROTEIN DYSBINDIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; PEDIGREE; POPULATION RESEARCH; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0037395091     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00527-3     Document Type: Article

References (17)

1. Benson M.A., Newey S.E., Martin-Rendon E., Hawkes R., Blake D.J. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J. Biol. Chem. 276:2001;24232-24241.
2. Hakonarson H., Bjornsdottir U.S., Halapi E., Palsson S., Adalsteinsdottir E., Gislason D., Finnbogason G., Gislason T., Kristjansson K., Arnason T., Birkisson I., Frigge M.L., Kong A., Gulcher J.R., Stefansson K. A major susceptibility gene for asthma maps to chromosome 14q24. Am. J. Hum. Genet. 71:2002;483-491.
3. Hugot J., Chamaillard M., Zouali H., Lesage S., Cezard J., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603.
4. Hwu H.G., Lin M.W., Lee P.C., Lee S.F., Ou-Yang W.C., Liu C.M. Evaluation of linkage of markers on chromosome 6p with schizophrenia in Taiwanese families. Am. J. Med. Genet. 96:2000;74-78.
5. Kendler K.S. The sporadic v. familial classification given aetiological heterogeneity: II. Power analyses. Psychol. Med. 18:1988;991-999.
6. Krawczak M., Konecki D.S., Schmidtke J., Duck M., Engel W., Nutzenadel W., Trefz F.K. Allelic association of the cystic fibrosis locus and two DNA markers, XV2c and KM19, in 55 German families. Hum. Genet. 80:1988;78-80.
7. Levinson D.F., Lewis C.M., Wise L.H.et al. Meta-analysis of genome scans for schizophrenia. Am. J. Med. Genet. 114(SL2):2002;697-890.
8. Lewontin R.C. The interaction of selection and linkage I general considerations: heterotic models. Genetics. 49:1964;49-67.
9. McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Levitt J.J., Fischer I.A., Shenton M.E. MRI anatomy of schizophrenia. Biol. Psychiatry. 45:1999;1099-1119.
10. Norton N., Williams N.M., Williams H.J., Spurlock G., Kirov G., Morris D.W., Hoogendoorn B., Owen M.J., O'Donovan M.C. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Hum. Genet. 110:2002;471-478.
11. Pastinen T., Partanen J., Syvanen A.C. Multiplex, fluorescent, solid phase minisequencing for efficient screening of DNA sequence variation. Clin. Chem. 42:1996;1391-1397.
12. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Am. J. Med. Genet. 67:1996;580-594.
13. Schwab S.G., Albus M., Hallmayer J., Honig S., Borrmann M., Lichtermann D., Ebstein R.P., Ackenheil M., Lerer B., Risch N., Maier W., Wildenauer D.B. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat. Genet. 11:1995;325-327.
14. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
15. Straub R.E., MacLean C.J., O'Neill F.A., Burke J., Murphy B., Duke F., Shinkwin R., Webb B.T., Zhang J., Walsh D., Kendler K.S. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat. Genet. 11:1995;287-293.
16. Straub R.E., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., O'Neill F.A., Walsh D., Kendler K.S. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol. Psychiatry. 7:2002;542-559.
17. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A., Wang X., O'Neill F.A., Walsh D., Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71:2002;337-348.